Global Spread of Carbapenemase-producing Enterobacteriaceae
暂无分享,去创建一个
[1] Y. Carmeli,et al. First Report on a Hyperepidemic Clone of KPC-3-Producing Klebsiella pneumoniae in Israel Genetically Related to a Strain Causing Outbreaks in the United States , 2008, Antimicrobial Agents and Chemotherapy.
[2] P. Nordmann,et al. Detection of an Ambler class D OXA-48-type β-lactamase in a Klebsiella pneumoniae strain in The Netherlands. , 2011, Journal of medical microbiology.
[3] G. Araj,et al. First detection of oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Morocco , 2010, Annals of tropical medicine and parasitology.
[4] D. Livermore,et al. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. , 2011, The Lancet. Infectious diseases.
[5] M. Falagas,et al. Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes. , 2011, Future microbiology.
[6] A. Seck,et al. Class D OXA-48 Carbapenemase in Multidrug-Resistant Enterobacteria, Senegal , 2011, Emerging infectious diseases.
[7] P. Nordmann,et al. Global spread of New Delhi metallo-β-lactamase 1. , 2010, The Lancet. Infectious diseases.
[8] Y. Carmeli,et al. Laboratory and Clinical Evaluation of Screening Agar Plates for Detection of Carbapenem-Resistant Enterobacteriaceae from Surveillance Rectal Swabs , 2011, Journal of Clinical Microbiology.
[9] P. Nordmann,et al. Use of ChromID Extended-Spectrum β-Lactamase Medium for Detecting Carbapenemase-Producing Enterobacteriaceae , 2010, Journal of Clinical Microbiology.
[10] P. Nordmann,et al. Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France. , 2011, The Journal of antimicrobial chemotherapy.
[11] Yehuda Carmeli,et al. Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality , 2007, Antimicrobial Agents and Chemotherapy.
[12] V. Miriagou,et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[13] D. Plachouras,et al. Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae. , 2008, The Journal of antimicrobial chemotherapy.
[14] Ronald N. Jones,et al. Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007 , 2010, Antimicrobial Agents and Chemotherapy.
[15] P. Nordmann,et al. How To Detect NDM-1 Producers , 2010, Journal of Clinical Microbiology.
[16] Kenneth S. Thomson,et al. Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase Issues , 2010, Journal of Clinical Microbiology.
[17] N. Woodford,et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.
[18] J. Quinn,et al. Worldwide Diversity of Klebsiella pneumoniae That Produce β-Lactamase blaKPC-2 Gene , 2010, Emerging infectious diseases.
[19] Timothy R. Walsh,et al. Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.
[20] K. Bush,et al. Carbapenemases: the Versatile β-Lactamases , 2007, Clinical Microbiology Reviews.
[21] P. Nordmann,et al. Evaluation of a DNA Microarray (Check-MDR CT102) for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum β-Lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 Carbapenemases , 2011, Journal of Clinical Microbiology.
[22] M. Toleman,et al. Global spread of New Delhi metallo-β-lactamase 1. , 2010, The Lancet. Infectious diseases.
[23] N. Woodford,et al. Redefining extended-spectrum beta-lactamases: balancing science and clinical need. , 2008, The Journal of antimicrobial chemotherapy.
[24] A. Fluit,et al. Global spread of New Delhi metallo-β-lactamase 1. , 2010, The Lancet. Infectious diseases.
[25] P. Nordmann,et al. Outbreak of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in France , 2011, Antimicrobial Agents and Chemotherapy.
[26] P. Nordmann,et al. Spread of OXA-48-Encoding Plasmid in Turkey and Beyond , 2010, Antimicrobial Agents and Chemotherapy.
[27] F. Baquero,et al. Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15 , 2008, Emerging infectious diseases.
[28] P. Nordmann,et al. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. , 2009, The Lancet. Infectious diseases.
[29] P. Nordmann,et al. Multiplex PCR for detection of acquired carbapenemase genes. , 2011, Diagnostic microbiology and infectious disease.
[30] Y. Arakawa,et al. Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens , 1995, Antimicrobial agents and chemotherapy.
[31] P. Nordmann,et al. Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[32] K. Bush,et al. Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2008, Antimicrobial Agents and Chemotherapy.
[33] Iraida E. Robledo,et al. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. , 2009, MMWR. Morbidity and mortality weekly report.
[34] P. Nordmann,et al. Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? , 2011, The Journal of antimicrobial chemotherapy.
[35] C. Bamia,et al. Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections , 2009, Antimicrobial Agents and Chemotherapy.
[36] Gopi Patel,et al. Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies , 2008, Infection Control & Hospital Epidemiology.
[37] P. Hsueh,et al. High burden of antimicrobial resistance in Asia. , 2011, International journal of antimicrobial agents.
[38] P. Nordmann,et al. Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae , 2004, Antimicrobial Agents and Chemotherapy.
[39] Timothy R. Walsh,et al. Metallo-β-Lactamases: the Quiet before the Storm? , 2005, Clinical Microbiology Reviews.
[40] K. Riesenberg,et al. Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia , 2009, Infection Control & Hospital Epidemiology.